| [ Summary ] |
Inflammatory bowel disease patients are commonly observed in elderly population and are likely to be related to age-related problems such as comorbidities, poly-pharmacy, decreased ADL, and altered cognitive function. They are also thought to be at slightly higher risk of developing certain infections and malignancies associated with immune-modulating medical therapies. However, clear cut distinctions are not available to define "elderly" patients. We must maximize QOL for elderly IBD patients. We must also take into account their wishes, along with their family's wishes, in relation to prognosis of comorbidities. We should not refrain from aggressive therapies simply because of their chronological age. |